Establishment Labs Holdings Inc.

NASDAQ:ESTA

Medical - Devices

Healthcare
$70.80 +3.21%

+$2.65 today

Market cap
$2.11B
Beta
1.11
P/E (TTM)
-57.6
EPS (TTM)
-$1.48
52W Low $33.35High $86.00

Volume 0.38M

Average 0.50M

ESTA Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Establishment Labs Holdings Inc.NASDAQ: ESTA

Gross Margin · Q3 FY2026 · quarter ended Sep 2026

Gross margin narrows to 69.1%

Gross margin was 69.1% in Q3 FY2026, down 1.0 pp from a year earlier. On a trailing-twelve-month basis it was 70.2%, up 1.4 pp year over year. Over 3 fiscal years it widened by 3.4 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
69.1%-1.6 pp QoQ
Last fiscal yearDec 2025
69.3%+3.3 pp YoY
LTMSep 2026
70.2%+1.4 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.0 pp——
1 year+3.3 pp——
3 years+3.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
69.3%
Year-over-year change
+3.3pp

Gross Margin vs competitors

How ESTA compares with its peers on the latest reported figures

  • ESTA's LTM Sep 2026 gross margin of 70.2% is the 2nd highest of the 4 companies compared; the peer median is 67.8%.
  • Its year-over-year change of +1.4 pp is the highest of 4, against a peer median of -0.3 pp.
  • Over three fiscal years its change of +3.4 pp compares with a peer median of -5.3 pp.
ESTA Competitors Peer median
Gross Margin for ESTA and competitors
Company Period LTM level YoY 3-year change
INMDInMode Ltd.LTM Mar 202677.8% -2.2 pp-5.3 pp
ESTAEstablishment Labs Holdings Inc.LTM Sep 202670.2% +1.4 pp+3.4 pp
TELATELA Bio, Inc.LTM Jun 202667.8% +0.5 pp+2.4 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202653.2% -0.3 pp-10.6 pp
Peer median (excluding ESTA) 67.8%-0.3 pp-5.3 pp

Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue126.68M161.7M165.15M166.03M211.08M
Cost of Revenue41.28M55.11M58.17M56.5M64.77M
Gross Profit85.4M106.6M106.98M109.53M146.31M
Gross Margin67.4%65.9%64.8%66.0%69.3%
Research & Development18.32M20.27M26.43M19.71M20.25M
Selling, General & Admin92.23M125.98M145.58M139.81M165.07M
Operating Expenses110.54M146.25M172M159.51M185.32M
Depreciation & Amortization4.12M4.34M4.88M7.58M10.47M
EBITDA(26.53M)(56.73M)(58.31M)(56.22M)(22.29M)
EBITDA Margin-20.9%-35.1%-35.3%-33.9%-10.6%
Operating Income(25.14M)(39.66M)(65.03M)(49.99M)(39.01M)
Operating Margin-19.8%-24.5%-39.4%-30.1%-18.5%
Interest Income23K87K1.02M1.48M423K
Interest Expense9.06M11.76M15.39M20.83M25.26M
Other Income / Expenses(14.57M)(33.17M)(13.56M)(34.64M)(19.01M)
Income Before Tax(39.71M)(72.82M)(78.58M)(84.63M)(58.02M)
Pre-Tax Margin-31.3%-45.0%-47.6%-51.0%-27.5%
Income Tax Expense1.43M2.39M(81K)(32K)(6.96M)
Net Income(41.14M)(75.21M)(78.5M)(84.6M)(51.06M)
Net Margin-32.5%-46.5%-47.5%-51.0%-24.2%
EPS (Basic)(1.72)(3.08)(3.07)(3.00)(1.72)
EPS (Diluted)(1.72)(3.08)(3.07)(3.00)(1.72)
Weighted Avg Shares23.97M24.46M25.6M28.16M29.62M
Weighted Avg Shares (Diluted)23.97M24.46M25.6M28.16M29.62M

Establishment Labs Holdings Inc.

NASDAQ:ESTA

Intrinsic Alpha fair value

Locked

Current Price

$70.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.